Early BCVA response may predict long-term outcomes of anti-VEGF treatment for DME

LAS VEGAS — Best corrected visual acuity response after three anti-VEGF injections for 12 weeks may be a strong predictor of long-term best corrected visual acuity response in patients with diabetic macular edema patients, according to a presentation here.In an assessment of Protocol I data from the DRCR.net, Pravin U. Dugel, MD, presented long-term treatment outcomes of anti-VEGF therapy in patients with diabetic macular edema at the American Academy of Ophthalmology annual meeting.

Full Story →